Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2000 2
2007 1
2008 1
2009 3
2010 2
2011 1
2012 2
2013 4
2014 3
2015 4
2016 4
2017 5
2018 5
2019 4
2020 5
2021 11
2022 4
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma.
Baggi A, Quaglino P, Rubatto M, Depenni R, Guida M, Ascierto PA, Trojaniello C, Queirolo P, Saponara M, Peris K, Spagnolo F, Bianchi L, De Galitiis F, Potenza MC, Proietti I, Marconcini R, Botticelli A, Barbieri V, Licitra L, Alfieri S, Ficorella C, Cortellini A, Fargnoli MC, Troiani T, Tondulli L, Bossi P. Baggi A, et al. Among authors: depenni r. Eur J Cancer. 2021 Nov;157:250-258. doi: 10.1016/j.ejca.2021.08.018. Epub 2021 Sep 15. Eur J Cancer. 2021. PMID: 34536948
Brain metastases: an overview.
Bertolini F, Spallanzani A, Fontana A, Depenni R, Luppi G. Bertolini F, et al. Among authors: depenni r. CNS Oncol. 2015;4(1):37-46. doi: 10.2217/cns.14.51. CNS Oncol. 2015. PMID: 25586424 Free PMC article. Review.
Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors.
Gibellini L, De Biasi S, Porta C, Lo Tartaro D, Depenni R, Pellacani G, Sabbatini R, Cossarizza A. Gibellini L, et al. Among authors: depenni r. Front Immunol. 2020 Mar 20;11:490. doi: 10.3389/fimmu.2020.00490. eCollection 2020. Front Immunol. 2020. PMID: 32265933 Free PMC article. Review.
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma.
Chiavelli C, Prapa M, Rovesti G, Silingardi M, Neri G, Pugliese G, Trudu L, Dall'Ora M, Golinelli G, Grisendi G, Vinet J, Bestagno M, Spano C, Papapietro RV, Depenni R, Di Emidio K, Pasetto A, Nascimento Silva D, Feletti A, Berlucchi S, Iaccarino C, Pavesi G, Dominici M. Chiavelli C, et al. Among authors: depenni r. NPJ Precis Oncol. 2024 Feb 1;8(1):26. doi: 10.1038/s41698-024-00506-z. NPJ Precis Oncol. 2024. PMID: 38302615 Free PMC article.
GD2 CAR T cells against human glioblastoma.
Prapa M, Chiavelli C, Golinelli G, Grisendi G, Bestagno M, Di Tinco R, Dall'Ora M, Neri G, Candini O, Spano C, Petrachi T, Bertoni L, Carnevale G, Pugliese G, Depenni R, Feletti A, Iaccarino C, Pavesi G, Dominici M. Prapa M, et al. Among authors: depenni r. NPJ Precis Oncol. 2021 Oct 27;5(1):93. doi: 10.1038/s41698-021-00233-9. NPJ Precis Oncol. 2021. PMID: 34707200 Free PMC article.
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.
Mandalà M, Lorigan P, Sergi MC, Benannoune N, Serra P, Vitale MG, Giannarelli D, Arance AM, Couselo EM, Neyns B, Tucci M, Guida M, Spagnolo F, Rossi E, Occelli M, Queirolo P, Quaglino P, Depenni R, Merelli B, Placzke J, Di Giacomo AM, Del Vecchio M, Indini A, da Silva IP, Menzies AM, Long GV, Robert C, Rutkowski P, Ascierto PA. Mandalà M, et al. Among authors: depenni r. Eur J Cancer. 2024 Mar;199:113542. doi: 10.1016/j.ejca.2024.113542. Epub 2024 Jan 19. Eur J Cancer. 2024. PMID: 38266540 Free article.
Is pain part of a systemic syndrome in head and neck cancer?
Bossi P, Ghiani M, Argenone A, Depenni R. Bossi P, et al. Among authors: depenni r. Support Care Cancer. 2020 Feb;28(2):451-459. doi: 10.1007/s00520-019-05147-8. Epub 2019 Nov 12. Support Care Cancer. 2020. PMID: 31713692 Review.
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile.
Ascierto PA, Di Giacomo AM, Chiarion Sileni V, Queirolo P, Spagnolo F, De Galitiis F, Cognetti F, Mandalà M, Guidoboni M, Rinaldi G, Depenni R, Consoli F, Troiani T, Guida M, Marconcini R, Ferrucci PF, Strippoli S, Fava P, Merelli B, Simeone E, Di Guardo L, Giannarelli D, Maio M, Quaglino P, Del Vecchio M. Ascierto PA, et al. Among authors: depenni r. Eur J Cancer. 2023 Sep;191:113246. doi: 10.1016/j.ejca.2023.113246. Epub 2023 Jul 19. Eur J Cancer. 2023. PMID: 37549531
Outcomes in patients with BRAFV600-mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib.
Aglietta M, Chiarion-Sileni V, Fava P, Guidoboni M, Depenni R, Minisini A, Consoli F, Ascierto PA, Rinaldi G, Banzi M, Marconcini R, Gueli R, Ferraresi V, Tucci M, Tonini G, Lo Re G, Guida M, Del Vecchio M, Marcon IG, Queirolo P. Aglietta M, et al. Among authors: depenni r. Tumori. 2023 Dec;109(6):537-545. doi: 10.1177/03008916231179251. Epub 2023 Jul 7. Tumori. 2023. PMID: 37417313 Free PMC article.
62 results